Clinical Trial Update: RCT of Gastric ESD With or Without Epineprhine Added Solution [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluated gastric endoscopic submucosal dissection with versus without an epinephrine-added solution; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastric Neoplasm

Drugs mentioned

• EPINEPHRINE (EPINEPHRINE)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Gastric Neoplasm, Early Gastric Cancer | Phase 3 | Status: COMPLETED